4.6 Article

Lithium Treatment of APPSwDI/NOS2-/- Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Tauopathies: One Disease or Many?

Manon Bouchard et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2011)

Article Geriatrics & Gerontology

Targeting Tau Protein in Alzheimer's Disease

Cheng-Xin Gong et al.

DRUGS & AGING (2010)

Article Neurosciences

Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability

Umesh K. Jinwal et al.

JOURNAL OF NEUROSCIENCE (2009)

Review Clinical Neurology

Structural principles of tau and the paired helical filaments of Alzheimer's disease

Eckhard Mandelkow et al.

BRAIN PATHOLOGY (2007)

Article Multidisciplinary Sciences

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

W Noble et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

L Petrucelli et al.

HUMAN MOLECULAR GENETICS (2004)

Article Multidisciplinary Sciences

Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model

M Ren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Geriatrics & Gerontology

Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice

G DiCarlo et al.

NEUROBIOLOGY OF AGING (2001)

Article Neurosciences

The effects of lithium on ex vivo cytokine production

MH Rapaport et al.

BIOLOGICAL PSYCHIATRY (2001)

Review Pharmacology & Pharmacy

Molecular targets of lithium action

CJ Phiel et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)

Review Geriatrics & Gerontology

Inflammation and Alzheimer's disease

H Akiyama et al.

NEUROBIOLOGY OF AGING (2000)